CHF129.60 Novartis (NOVN.SW, SIX) intraday 26 Feb 2026: Meyka sees 18.35% upside
Intraday NOVN.SW stock update: Novartis at CHF129.60 on SIX, volume 3.67M, Meyka forecast shows 18.35% five-year upside
Intraday NOVN.SW stock update: Novartis at CHF129.60 on SIX, volume 3.67M, Meyka forecast shows 18.35% five-year upside
Pre-market look at 198A.T stock on 27 Feb 2026 — price, Meyka grade, forecasts and downside risks
Pre-market look at 0657.HK stock on 27 Feb 2026 — price, volume, valuation and Meyka AI forecast for investors
Intraday report: VNA.DE stock at €27.80 on XETRA with 4.78M volume; grade, valuation and forecast
UBS Credit Suisse integration enters its final phase as UBS starts shutting Credit Suisse platforms from end-March. See the migration timeline, impact on Swiss clients, cost synergies, and UBS stock’s
JYEU.SI stock pre-market snapshot S$0.60 with heavy volume and Meyka AI forecast for 12 months
Intraday earnings spotlight on PPL.TO stock — price, dividend yield, Meyka AI forecast and analyst targets for 26 Feb 2026
TMG.AX stock jumps 9.09% pre-market to A$0.12 on ASX; Meyka AI flags A$0.22 12‑month target and catalysts
SNOW stock slips after hours as Snowflake lifts AI revenue guidance to US$5.66B for FY2027 and Q1 to US$1.26–1.27B. See what this means for Canadian investors, risks, and key levels.
EOSE stock drops intraday after premarket earnings on 26 Feb 2026; Meyka AI forecast and price targets explained